Class Action

DayQuil, NyQuil, and Theraflu

Class Action

DayQuil, NyQuil, and Theraflu


Case Name (Date)

Juneau et al. v. The Procter & Gamble Co. and GSK Consumer Healthcare, Inc.
23-cv-5273, E.D. La.
(Sept. 2023)


Product/Service

DayQuil Severe, NyQuil Severe Cold & Flu, Theraflu Multi-Symptom Severe Cold/Severe Cold Cough, and other cold and flu medicines


Allegations

Falsely marketing that medicines treat nasal congestion when the active ingredient (phenylephrine) is not an effective decongestant


Status

Pending



Class-Action Tracker


The Latest

Filters

Microban 24

Ad Alert

Microban 24

Sanitizing spray does not provide 24-hour protection against viruses, despite what its TV commercial may make you think.

Benefiber

Ad Alert

Benefiber

If you see a supplement marketed as “clinically proven,” pump your brakes.


Show More